Albireo Pharma Inc is a development-stage pharmaceutical company. It engages in the research and development of the drug reformulation technology. The company is engaged in the development an oral insulin to treat diabetes.
$35.82 -1.42 (-3.81%)
As of 03/02/2021 15:59:42 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.